Provided by Tiger Fintech (Singapore) Pte. Ltd.

Edgewise Therapeutics, Inc.

14.30
-0.5500-3.70%
Post-market: 14.300.00000.00%16:10 EDT
Volume:485.38K
Turnover:6.98M
Market Cap:1.51B
PE:-9.22
High:14.86
Open:14.86
Low:14.21
Close:14.85
52wk High:38.12
52wk Low:10.60
Shares:105.35M
Float Shares:60.53M
Volume Ratio:0.82
T/O Rate:0.80%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.5508
EPS(LYR):-1.4480
ROE:-27.41%
ROA:-19.06%
PB:2.56
PE(LYR):-9.88

Loading ...

Edgewise Therapeutics Reports New Results From Phase 2 Hypertrophic Cardiomyopathy Trial

MT Newswires Live
·
Apr 02

Edgewise Therapeutics Prices $200 Million Offering

MT Newswires Live
·
Apr 02

BRIEF-Edgewise Therapeutics Announces Pricing Of $200 Million Underwritten Offering Of Common Stock

Reuters
·
Apr 02

Edgewise Therapeutics Announces Pricing of $200 Million Underwritten Offering of Common Stock

PR Newswire
·
Apr 02

BRIEF-Edgewise Therapeutics Announces Positive Top-Line Results From Phase 2 CIRRUS-HCM Four-Week Trial of EDG-7500 in Hypertrophic Cardiomyopathy

Reuters
·
Apr 02

Edgewise Therapeutics to Host Webcast Event to Discuss Top-Line Results from Phase 2 CIRRUS-HCM 28-Day Trial of EDG-7500 in Hypertrophic Cardiomyopathy (HCM) on Wednesday, April 2 at 8:30 am Eastern Time

PR Newswire
·
Mar 27

Edgewise Therapeutics to Present on Sevasemten for the Treatment of Becker Muscular Dystrophy at the 2025 MDA Clinical and Scientific Conference

Business Wire
·
Mar 11

Stock Track | Edgewise Therapeutics, Inc. (EWTX) Soars 5.33% on Analyst Optimism

Stock Track
·
Mar 07

Analysts Have Conflicting Sentiments on These Healthcare Companies: Edgewise Therapeutics (EWTX) and Walgreens Boots Alliance (WBA)

TIPRANKS
·
Mar 07

Edgewise Therapeutics initiated with an Outperform at Scotiabank

TIPRANKS
·
Mar 07

Edgewise Therapeutics: Promising Pipeline and Upcoming Data Readouts Reinforce Buy Rating

TIPRANKS
·
Mar 05

Edgewise Therapeutics to Present at the Leerink Partners Global Healthcare Conference on March 11, 2025

Business Wire
·
Mar 04

Edgewise Therapeutics (EWTX) Gets a Buy from RBC Capital

TIPRANKS
·
Mar 04

Edgewise Therapeutics (EWTX) Receives a Buy from Evercore ISI

TIPRANKS
·
Mar 04

Edgewise Therapeutics Reports 2024 Financial Results and Progress

TIPRANKS
·
Mar 04

Edgewise Therapeutics Reports Wider-Than-Expected Q4 Net Loss

MT Newswires Live
·
Mar 03

Earnings Flash (EWTX) Edgewise Therapeutics Posts Q4 Total Operating Expenses $45.5M

MT Newswires Live
·
Mar 03

Earnings Flash (EWTX) Edgewise Therapeutics Posts Q4 Net Loss $0.42 a Share, vs. FactSet Est of $0.37 Loss

MT Newswires Live
·
Mar 03

BRIEF-Edgewise Therapeutics Q4 Basic EPS USD -0.42

Reuters
·
Mar 03

Press Release: Edgewise Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights

Dow Jones
·
Mar 03